Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-47
Closed -$2.4K – 823
2025
Q3
$2.4K Sell
47
-4
-8% -$207 ﹤0.01% 757
2025
Q2
$2.66K Hold
51
– – ﹤0.01% 730
2025
Q1
$3.08K Buy
+51
New +$3.29K ﹤0.01% 734
2024
Q4
– Sell
-51
Closed -$3.67K – 809
2024
Q3
$3.67K Sell
51
-51
-50% -$3.6K ﹤0.01% 754
2024
Q2
$7.07K Hold
102
– – ﹤0.01% 490
2024
Q1
$8.17K Hold
102
– – ﹤0.01% 485
2023
Q4
$11.2K Buy
+102
New +$10.5K ﹤0.01% 463

Other funds holding CNMD

NBT Bank's CNMD Position: Q4 2025 in Review

NBT Bank sold out of CONMED (CNMD) in Q4 2025, closing a stake of 47 shares — an estimated $2.4K sold.

NBT Bank first reported a position in CNMD in Q4 2023 and held it in 7 quarters. The position peaked at $11.2K in Q4 2023. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • NBT Bank reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
  • NBT Bank sold 47 CONMED shares in Q4 2025, an estimated $2.4K.
  • NBT Bank first reported a position in CONMED in Q4 2023 and held it in 7 quarters.
  • NBT Bank's CONMED position peaked at $11.2K in Q4 2023.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on NBT Bank's 13F filing for Q4 2025, filed 23 Jan 2026.